APO RESEARCH · REPORT
Radioactive Source
A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.
Product & engineering
Understand the product.
A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.
Selected research
Industry Research
Radioactive Source Industry Research Report 2026
Market perspective
A radioactive source is a known quantity of a radionuclide which emits ionizing radiation; typically, one or more of the radiation types gamma rays, alpha particles, beta particles, and neutron radiation.
NRG and Mayak maintained absolute dominance in the global radioactive source manufacturers ranking in 2019, together accounted for about 35% of the market share.
Report Scope
Read the full market overview
This report quantifies the global Radioactive Source market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Radioactive Source.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Radioactive Source Market by Company
NRG
Mayak
NTP Radioisotopes
ANSTO
Nordion
IRE
Curium Pharma
Eckert & Ziegler Strahlen
China Isotope & Radiation Corporation (CIRC)
Polatom
Board of Radiation and Isotope Technology
Radioactive Source Segment by Type
Mo-99
Co-60
Na-22
Co-57
Sr-90
I-131
Ir-192
Se-75
Kr-85
Am-241
Radioactive Source Segment by Application
Medical
Industrial
Agriculture
Scientific Research
Others
Radioactive Source Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioactive Source market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radioactive Source and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioactive Source.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Radioactive Source companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mo-99
- Co-60
- Na-22
- Co-57
- Sr-90
- I-131
- Ir-192
- Se-75
- Kr-85
- Am-241
Applications
- Medical
- Industrial
- Agriculture
- Scientific Research
- Others
Companies covered
- NRG
- Mayak
- NTP Radioisotopes
- ANSTO
- Nordion
- IRE
- Curium Pharma
- Eckert & Ziegler Strahlen
- China Isotope & Radiation Corporation (CIRC)
- Polatom
- Board of Radiation and Isotope Technology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Radioactive Source by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Mo-99
- 2.2.3 Co-60
- 2.2.4 Na-22
- 2.2.5 Co-57
- 2.2.6 Sr-90
- 2.2.7 I-131
- 2.2.8 Ir-192
- 2.2.9 Se-75
- 2.2.10 Kr-85
- 2.2.11 Am-241
- 2.3 Radioactive Source by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical
- 2.3.3 Industrial
- 2.3.4 Agriculture
- 2.3.5 Scientific Research
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Radioactive Source Breakdown Data by Type
- 3.1 Global Radioactive Source Historic Market Size by Type (2021-2026)
- 3.2 Global Radioactive Source Forecasted Market Size by Type (2027-2032)
4 Radioactive Source Breakdown Data by Application
- 4.1 Global Radioactive Source Historic Market Size by Application (2021-2026)
- 4.2 Global Radioactive Source Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Radioactive Source Market Perspective (2021-2032)
- 5.2 Global Radioactive Source Growth Trends by Region
- 5.2.1 Global Radioactive Source Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Radioactive Source Historic Market Size by Region (2021-2026)
- 5.2.3 Radioactive Source Forecasted Market Size by Region (2027-2032)
- 5.3 Radioactive Source Market Dynamics
- 5.3.1 Radioactive Source Industry Trends
- 5.3.2 Radioactive Source Market Drivers
- 5.3.3 Radioactive Source Market Challenges
- 5.3.4 Radioactive Source Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Radioactive Source Players by Revenue
- 6.1.1 Global Top Radioactive Source Players by Revenue (2021-2026)
- 6.1.2 Global Radioactive Source Revenue Market Share by Players (2021-2026)
- 6.2 Global Radioactive Source Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Radioactive Source Head Office and Area Served
- 6.4 Global Radioactive Source Players, Product Type & Application
- 6.5 Global Radioactive Source Manufacturers Established Date
- 6.6 Global Radioactive Source Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Radioactive Source Market Size (2021-2032)
- 7.2 North America Radioactive Source Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Radioactive Source Market Size by Country (2021-2026)
- 7.4 North America Radioactive Source Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Radioactive Source Market Size (2021-2032)
- 8.2 Europe Radioactive Source Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Radioactive Source Market Size by Country (2021-2026)
- 8.4 Europe Radioactive Source Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Radioactive Source Market Size (2021-2032)
- 9.2 Asia-Pacific Radioactive Source Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Radioactive Source Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Radioactive Source Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Radioactive Source Market Size (2021-2032)
- 10.2 South America Radioactive Source Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Radioactive Source Market Size by Country (2021-2026)
- 10.4 South America Radioactive Source Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Radioactive Source Market Size (2021-2032)
- 11.2 Middle East & Africa Radioactive Source Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Radioactive Source Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Radioactive Source Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 NRG
- 12.1.1 NRG Company Information
- 12.1.2 NRG Business Overview
- 12.1.3 NRG Revenue in Radioactive Source Business (2021-2026)
- 12.1.4 NRG Radioactive Source Product Portfolio
- 12.1.5 NRG Recent Developments
- 12.2 Mayak
- 12.2.1 Mayak Company Information
- 12.2.2 Mayak Business Overview
- 12.2.3 Mayak Revenue in Radioactive Source Business (2021-2026)
- 12.2.4 Mayak Radioactive Source Product Portfolio
- 12.2.5 Mayak Recent Developments
- 12.3 NTP Radioisotopes
- 12.3.1 NTP Radioisotopes Company Information
- 12.3.2 NTP Radioisotopes Business Overview
- 12.3.3 NTP Radioisotopes Revenue in Radioactive Source Business (2021-2026)
- 12.3.4 NTP Radioisotopes Radioactive Source Product Portfolio
- 12.3.5 NTP Radioisotopes Recent Developments
- 12.4 ANSTO
- 12.4.1 ANSTO Company Information
- 12.4.2 ANSTO Business Overview
- 12.4.3 ANSTO Revenue in Radioactive Source Business (2021-2026)
- 12.4.4 ANSTO Radioactive Source Product Portfolio
- 12.4.5 ANSTO Recent Developments
- 12.5 Nordion
- 12.5.1 Nordion Company Information
- 12.5.2 Nordion Business Overview
- 12.5.3 Nordion Revenue in Radioactive Source Business (2021-2026)
- 12.5.4 Nordion Radioactive Source Product Portfolio
- 12.5.5 Nordion Recent Developments
- 12.6 IRE
- 12.6.1 IRE Company Information
- 12.6.2 IRE Business Overview
- 12.6.3 IRE Revenue in Radioactive Source Business (2021-2026)
- 12.6.4 IRE Radioactive Source Product Portfolio
- 12.6.5 IRE Recent Developments
- 12.7 Curium Pharma
- 12.7.1 Curium Pharma Company Information
- 12.7.2 Curium Pharma Business Overview
- 12.7.3 Curium Pharma Revenue in Radioactive Source Business (2021-2026)
- 12.7.4 Curium Pharma Radioactive Source Product Portfolio
- 12.7.5 Curium Pharma Recent Developments
- 12.8 Eckert & Ziegler Strahlen
- 12.8.1 Eckert & Ziegler Strahlen Company Information
- 12.8.2 Eckert & Ziegler Strahlen Business Overview
- 12.8.3 Eckert & Ziegler Strahlen Revenue in Radioactive Source Business (2021-2026)
- 12.8.4 Eckert & Ziegler Strahlen Radioactive Source Product Portfolio
- 12.8.5 Eckert & Ziegler Strahlen Recent Developments
- 12.9 China Isotope & Radiation Corporation (CIRC)
- 12.9.1 China Isotope & Radiation Corporation (CIRC) Company Information
- 12.9.2 China Isotope & Radiation Corporation (CIRC) Business Overview
- 12.9.3 China Isotope & Radiation Corporation (CIRC) Revenue in Radioactive Source Business (2021-2026)
- 12.9.4 China Isotope & Radiation Corporation (CIRC) Radioactive Source Product Portfolio
- 12.9.5 China Isotope & Radiation Corporation (CIRC) Recent Developments
- 12.10 Polatom
- 12.10.1 Polatom Company Information
- 12.10.2 Polatom Business Overview
- 12.10.3 Polatom Revenue in Radioactive Source Business (2021-2026)
- 12.10.4 Polatom Radioactive Source Product Portfolio
- 12.10.5 Polatom Recent Developments
- 12.11 Board of Radiation and Isotope Technology
- 12.11.1 Board of Radiation and Isotope Technology Company Information
- 12.11.2 Board of Radiation and Isotope Technology Business Overview
- 12.11.3 Board of Radiation and Isotope Technology Revenue in Radioactive Source Business (2021-2026)
- 12.11.4 Board of Radiation and Isotope Technology Radioactive Source Product Portfolio
- 12.11.5 Board of Radiation and Isotope Technology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst